AL

Allen S. Lichter

Scientific Advisor at Ascentage Pharma

Allen S. Lichter, MD, FASCO, is a prominent leader in the field of oncology, having served as CEO of the American Society of Clinical Oncology (ASCO) and the Conquer Cancer Foundation of ASCO from 2006-2016. He has been an ASCO member since 1980 and has held many prominent roles in the Society, including President and Founding Chair of the Board of Governors of CancerLinQ—ASCO’s health information technology platform. Prior to his tenure at ASCO, Dr. Lichter was a dean of the University of Michigan Medical School (1998-2006) and the Chair and Professor of Radiation Oncology (1984-1998). At the University of Michigan Comprehensive Cancer Center, he also served as Director of the Breast Oncology Program (1984 to 1991), and was the first Isadore Lampe Professor of Radiation Oncology, an endowed chair, and the Newman Family Professor of Radiation Oncology. Earlier in his career, Dr. Lichter served as Director of the Radiation Therapy Section of the National Cancer Institute’s Radiation Oncology Branch. Dr. Lichter’s research and development of three-dimensional treatment planning led to a Gold Medal from the American Society for Radiation Oncology, and he is an elected member of the National Academies of Science.

Timeline

  • Scientific Advisor

    Current role